TFs, including CEBPB, IRF3, NFKB2, and PRDM1, regulated immune and inflammatory responses and displayed enhanced activity in ITP, consistent with the results of gene expression data analysis. This evidence concerns the gene CEBPB and autoimmune thrombocytopenic purpura.